GlassScriptPhysician profile
Hetal S Shah
NPI 1497784094
$18,376.34
in general payments reported to CMS, 2019-2025
75 companies · $2,897 in 2025
The $2,897 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,614 · 2020: $1,908 · 2021: $2,415 · 2022: $2,925 · 2023: $2,649 · 2024: $2,969 · 2025: $2,897.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,514.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,971.69 | 2019-2025 | Qulipta, Vraylar, Ubrelvy |
| Novo Nordisk INC | $1,898.29 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,563.73 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $1,155.74 | 2019-2025 | Evenity, Prolia, Repatha |
| Glaxosmithkline, LLC. | $983.46 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $968.95 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $743.51 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Otsuka America Pharmaceutical, INC. | $660.34 | 2019-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Abbott Laboratories | $598.00 | 2019-2025 | Freestyle Libre 3, Aveir |
| Lilly USA, LLC | $579.13 | 2019-2025 | Zepbound, Jardiance, Mounjaro |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $543.17 | 2019-2025 | Xifaxan |
| Amarin Pharma, INC. | $431.55 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $423.63 | 2022 | |
| Antares Pharma, INC. | $406.06 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Merck Sharp & Dohme LLC | $343.53 | 2019-2025 | Gardasil 9, Capvaxive, Verquvo |
Show all 75 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $318.48 | 2021-2025 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $296.82 | 2020-2025 | Austedo Xr, Austedo, Austedo Xr |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $259.43 | 2022-2025 | Caplyta |
| Eisai INC. | $255.62 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $212.56 | 2019-2023 | Seglentis |
| Bayer Healthcare Pharmaceuticals INC. | $212.38 | 2023-2025 | |
| Allergan, INC. | $200.95 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $183.87 | 2019-2025 | Trintellix |
| Phathom Pharmaceuticals, INC. | $175.66 | 2024-2025 | Voquezna |
| Dexcom, INC. | $175.38 | 2022-2025 | Dexcom G6 Transmitter |
| Idorsia Pharmaceuticals US INC | $154.13 | 2022-2024 | Quviviq |
| Alkermes, INC. | $150.26 | 2022-2024 | Aristada, Lybalvi, Vivitrol |
| Exact Sciences Corporation | $140.78 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $131.21 | 2019-2025 | Veozah, Vesicare |
| Collegium Pharmaceutical, INC. | $117.91 | 2021-2025 | Belbuca |
| Ardelyx, INC. | $115.20 | 2024-2025 | Ibsrela |
| Ibsa Pharma INC. | $112.54 | 2019-2025 | Tirosint, Licart, Flector |
| Novartis Pharmaceuticals Corporation | $110.74 | 2019-2023 | |
| Vanda Pharmaceuticals INC. | $109.19 | 2025 | Fanapt |
| Currax Pharmaceuticals LLC | $105.02 | 2019-2023 | Nexlizet, Contrave, Onzetra Xsail |
| Janssen Pharmaceuticals, INC | $101.79 | 2019-2025 | Spravato |
| Almatica Pharma LLC | $89.48 | 2022-2024 | Loreev Xr, Sertraline Hcl, Teriparatide |
| Axsome Therapeutics, INC. | $85.97 | 2024-2025 | Auvelity |
| Daiichi Sankyo INC. | $83.80 | 2019-2023 | Injectafer |
| Biohaven Pharmaceuticals, INC. | $81.87 | 2021 | |
| Adlon Therapeutics L.P. | $79.33 | 2019-2021 | |
| Halozyme INC | $78.77 | 2023 | |
| Corium, LLC | $76.91 | 2023-2024 | Azstarys |
| Jazz Pharmaceuticals INC. | $64.85 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $61.65 | 2019-2025 | |
| Sanofi Pasteur INC. | $52.15 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $48.24 | 2020-2022 | |
| Bausch Health US, LLC | $45.82 | 2019-2022 | |
| Ironwood Pharmaceuticals, INC | $45.53 | 2022-2024 | |
| Vivus LLC | $38.32 | 2019-2021 | |
| Harmony Biosciences LLC | $32.59 | 2025 | |
| Nevro Corp. | $31.82 | 2023 | Senza |
| Corcept Therapeutics | $31.39 | 2025 | Korlym |
| Neos Therapeutics, LP | $30.09 | 2024 | Adzenys Xr-Odt |
| Clarus Therapeutics INC. | $29.29 | 2021 | |
| Althera Pharmaceuticals LLC | $28.89 | 2021 | |
| Baxter Healthcare | $28.63 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Kaleo, INC. | $28.07 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $26.36 | 2019-2021 | |
| Neotract INC. | $26.04 | 2019 | |
| Hikma Pharmaceuticals USA | $24.06 | 2019-2020 | |
| Valeritas, INC. | $20.86 | 2019 | |
| Aytu Biopharma, INC. | $18.62 | 2020 | |
| Edwards Lifesciences Corporation | $18.25 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Si-Bone, INC. | $17.04 | 2024 | |
| Ucb, INC. | $16.15 | 2022 | |
| Xeris Pharmaceuticals, INC. | $15.27 | 2023 | Gvoke Hypopen |
| Endo Pharmaceuticals INC. | $14.79 | 2020 | |
| Esperion Therapeutics, INC. | $14.75 | 2021 | |
| Circassia INC. | $14.58 | 2019 | |
| Metuchen Pharmaceuticals | $14.51 | 2019 | |
| Seqirus USA INC | $13.70 | 2019 | |
| Redhill Biopharma INC. | $13.20 | 2021 | |
| Genentech USA, INC. | $12.37 | 2022 | |
| Horizon Therapeutics Plc | $11.63 | 2021 |
Drugs and devices associated with these payments
Ozempic $746Rybelsus $653Rexulti $621Nurtec Odt $507Vraylar $461Evenity $422Zavzpret $386Jardiance $386Farxiga $375Qulipta $373Airsupra $333Wegovy $333Ubrelvy $332Breztri $270Prolia $249Freestyle Libre 3 $244Kerendia $212Aristada $200Xyosted $196Xifaxan $196Zepbound $182Voquezna $176Otezla $173Repatha $173Mounjaro $167Trelegy Ellipta $164Dexcom G6 Transmitter $147Tradjenta $146Quviviq $126Lybalvi $121Aveir $118Ibsrela $115Austedo Xr $111Fanapt $109Belbuca $103Veozah $87.63Cologuard Collection Kit $86.70Auvelity $85.97Synjardy $82.52Paxlovid $77.67Azstarys $76.91Emgality $74.57Trijardy Xr $63.94Glyxambi $63.94Abilify Asimtufii $63.21The Cologuard Plus Collection Kit $54.08Arexvy $53.21Caplyta $52.62Gardasil 9 $50.53Abilify Maintena $49.81Loreev Xr $48.09Tirosint $46.86Seglentis $46.31Rinvoq $43.05Prevnar 20 $40.16Abrysvo $40.16Comirnaty $40.16Trulicity $35.96Capvaxive $34.22Wakix $32.59Licart $32.34Trintellix $32.24Senza $31.82Verquvo $31.74Korlym $31.39Shingrix $31.36Sertraline Hcl $31.09Adzenys Xr-Odt $30.09Hillrom - Carnation Ambulatory Monitor $28.63Austedo $28.29Calquence $27.00Eliquis $25.47Tzield $19.63Edwards Sapien 3 Ultra Transcatheter Heart Valve $18.25Linzess $17.88Spravato $17.87Flector $17.82Krystexxa $17.26Teriparatide $17.00Proquad $16.31Saxenda $16.04Entresto $16.02Leqvio $16.02Ajovy $15.98Steglatro $15.87Belsomra $15.87Gralise $15.67Vesicare $15.28Gvoke Hypopen $15.27Viberzi $14.47Injectafer $13.62Contrave $13.61Onzetra Xsail $13.61Nexlizet $13.61Nexletol $13.61Nocdurna $13.57Tlando $13.57Vivitrol $12.95
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hetal Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.